(Q38031760)

27 August 2017

title

Local targets for immune therapy to cancer: tumor draining lymph nodes and tumor microenvironment (English)

1 reference

27 August 2017

0 references

1 reference

Cornelis J. M. Melief

series ordinal

3

object named as

Cornelis J M Melief

1 reference

27 August 2017

Marieke F Fransen

1

1 reference

27 August 2017

Ramon Arens

series ordinal

2

1 reference

27 August 2017

language of work or name

English

0 references

publication date

16 August 2012

1 reference

International Journal of Cancer

27 August 2017

published in

1 reference

27 August 2017

volume

132

1 reference

27 August 2017

issue

9

1 reference

27 August 2017

page(s)

1971-1976

1 reference

Immune surveillance of tumors

27 August 2017

cites work

1 reference

Cancer immunoediting: from immunosurveillance to tumor escape

21 January 2018

1 reference

Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion

21 January 2018

1 reference

Prognostic impact of isolated tumor cells and micrometastases in axillary lymph nodes of breast cancer patients

21 January 2018

1 reference

Detection of melanoma micrometastases in sentinel nodes - the cons

21 January 2018

1 reference

Sentinel-node biopsy or nodal observation in melanoma

21 January 2018

1 reference

Natural innate and adaptive immunity to cancer

21 January 2018

1 reference

IFNgamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity

21 January 2018

1 reference

Perforin-mediated cytotoxicity is critical for surveillance of spontaneous lymphoma

21 January 2018

1 reference

Role of IFN regulatory factor-1 and IL-12 in immunological resistance to pathogenesis of N-methyl-N-nitrosourea-induced T lymphoma

21 January 2018

1 reference

Natural immunity to cancer in humans

21 January 2018

1 reference

Endogenous T cell responses to antigens expressed in lung adenocarcinomas delay malignant tumor progression

21 January 2018

1 reference

Type, density, and location of immune cells within human colorectal tumors predict clinical outcome

21 January 2018

1 reference

Unique human tumor antigens: immunobiology and use in clinical trials

21 January 2018

1 reference

Tumor growth enhances cross-presentation leading to limited T cell activation without tolerance

21 January 2018

1 reference

Maturation of dendritic cells and T-cell responses in sentinel lymph nodes from patients with breast carcinoma.

21 January 2018

1 reference

Cancer immunotherapy by dendritic cells

21 January 2018

1 reference

Tumour-induced immune modulation of sentinel lymph nodes

21 January 2018

1 reference

Selective Modulation of Paracortical Dendritic Cells and T-Lymphocytes in Breast Cancer Sentinel Lymph Nodes

21 January 2018

1 reference

Transcriptional mechanisms underlying lymphocyte tolerance.

21 January 2018

1 reference

Incomplete differentiation of antigen-specific CD8 T cells in tumor-draining lymph nodes

21 January 2018

1 reference

Cutting edge: tumor-specific CTL are constitutively cross-armed in draining lymph nodes and transiently disseminate to mediate tumor regression following systemic CD40 activation

21 January 2018

1 reference

Effector function of human tumor-specific CD8 T cells in melanoma lesions: a state of local functional tolerance

21 January 2018

1 reference

Regulated expression of a tumor-associated antigen reveals multiple levels of T-cell tolerance in a mouse model of lung cancer

21 January 2018

1 reference

Tumor masses support naive T cell infiltration, activation, and differentiation into effectors

21 January 2018

1 reference

The tumor-draining lymph node as an immune-privileged site

21 January 2018

1 reference

Indoleamine 2,3-dioxygenase controls conversion of Foxp3+ Tregs to TH17-like cells in tumor-draining lymph nodes.

21 January 2018

1 reference

Foxp3+ T cells induce perforin-dependent dendritic cell death in tumor-draining lymph nodes

21 January 2018

1 reference

Granzyme B and perforin are important for regulatory T cell-mediated suppression of tumor clearance

21 January 2018

1 reference

Immunosenescence and cancer

21 January 2018

1 reference

Suppressing an anti-inflammatory cytokine reveals a strong age-dependent survival cost in mice

21 January 2018

1 reference

Twelve immunotherapy drugs that could cure cancers

21 January 2018

1 reference

Cancer immunotherapy: co-stimulatory agonists and co-inhibitory antagonists.

21 January 2018

1 reference

Enhanced efficacy and reduced toxicity of multifactorial adjuvants compared with unitary adjuvants as cancer vaccines.

21 January 2018

1 reference

Targeting CpG oligonucleotides to the lymph node by nanoparticles elicits efficient antitumoral immunity.

21 January 2018

1 reference

Cytokine storm in a phase 1 trial of the anti-CD28 monoclonal antibody TGN1412

21 January 2018

1 reference

Clinical activity and immune modulation in cancer patients treated with CP-870,893, a novel CD40 agonist monoclonal antibody.

21 January 2018

1 reference

Guidelines for the safe administration of high-dose interleukin-2.

21 January 2018

1 reference

High-dose granulocyte-macrophage colony-stimulating factor-producing vaccines impair the immune response through the recruitment of myeloid suppressor cells

21 January 2018

1 reference

Delivery of immunostimulatory RNA oligonucleotides by gelatin nanoparticles triggers an efficient antitumoral response.

21 January 2018

1 reference

Route of administration of the TLR9 agonist CpG critically determines the efficacy of cancer immunotherapy in mice

21 January 2018

1 reference

In situ vaccination with a TLR9 agonist induces systemic lymphoma regression: a phase I/II study

21 January 2018

1 reference

Regulation of dendritic cell migration to the draining lymph node: impact on T lymphocyte traffic and priming

21 January 2018

1 reference

Deliberately provoking local inflammation drives tumors to become their own protective vaccine site.

21 January 2018

1 reference

Separate roles for antigen recognition and lymph node inflammation in CD8+ memory T cell formation

21 January 2018

1 reference

Local activation of CD8 T cells and systemic tumor eradication without toxicity via slow release and local delivery of agonistic CD40 antibody

21 January 2018

1 reference

CD40 agonists alter tumor stroma and show efficacy against pancreatic carcinoma in mice and humans

21 January 2018

1 reference

Formulation aspects of biodegradable polymeric microspheres for antigen delivery

21 January 2018

1 reference

In situ gelling hydrogels for pharmaceutical and biomedical applications

21 January 2018

1 reference

Immunological aspects of cancer chemotherapy

21 January 2018

1 reference

Chemotherapy enhances tumor cell susceptibility to CTL-mediated killing during cancer immunotherapy in mice

21 January 2018

1 reference

Autoimmunity correlates with tumor regression in patients with metastatic melanoma treated with anti-cytotoxic T-lymphocyte antigen-4.

21 January 2018

1 reference

Myeloid-derived suppressor cells: linking inflammation and cancer

21 January 2018

1 reference

Intradermal CpG-B activates both plasmacytoid and myeloid dendritic cells in the sentinel lymph node of melanoma patients

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/IJC.27755

1 reference

27 August 2017

1 reference